These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 3547262)
1. [Methylation of membrane phospholipids of alveolar macrophages in pulmonary sarcoidosis and diffuse interstitial pulmonary fibrosis]. Pacheco Y; Fonlupt P; Dubois M; Biot N; Perrin-Fayolle M; Pacheco H Pathol Biol (Paris); 1986 Dec; 34(10):1067-73. PubMed ID: 3547262 [TBL] [Abstract][Full Text] [Related]
2. Alveolar macrophage membrane phospholipid methylation in sarcoidosis and hypersensitivity pneumonitis. Pacheco Y; Fonlupt P; Rey C; Biot N; Vergnon JM; Douss T; Pacheco H; Perrin-Fayolle M Bull Eur Physiopathol Respir; 1986; 22(6):565-72. PubMed ID: 3828547 [TBL] [Abstract][Full Text] [Related]
3. [Analysis by broncho-alveolar lavage of the pulmonary uptake of gallium 67 in idiopathic diffuse interstitial fibrosis and sarcoidosis]. Vergnon JM; Lahneche B; Ripoll JP; Pages J; Chauvot P; Brune J Rev Mal Respir; 1987; 4(2):85-93. PubMed ID: 3589113 [TBL] [Abstract][Full Text] [Related]
4. Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Hunninghake GW Am Rev Respir Dis; 1984 Apr; 129(4):569-72. PubMed ID: 6608889 [TBL] [Abstract][Full Text] [Related]
6. [Membrane phosphatidylethanolamine methylase in blood leukocytes and alveolar macrophages of asthmatic patients]. Pacheco Y; Fonlupt P; Bensoussan P; Collas R; Biot N; Rey C; Pacheco H; Perrin-Fayolle M Rev Pneumol Clin; 1985; 41(1):47-56. PubMed ID: 4001746 [TBL] [Abstract][Full Text] [Related]
7. [Macrophage-lymphocyte alveolitis in pulmonary sarcoidosis. The role of T-lymphocytes and alveolar macrophages in the pathogenesis and monitoring of this disease]. Rossi GA; Vassalo F; Sacco O; Cerri E; Degl'Innocenti L Rev Mal Respir; 1988; 5(5):511-8. PubMed ID: 3055098 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. Bitterman PB; Adelberg S; Crystal RG J Clin Invest; 1983 Nov; 72(5):1801-13. PubMed ID: 6630527 [TBL] [Abstract][Full Text] [Related]
10. Protein profile in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis as revealed by SDS-PAGE electrophoresis and western blot analysis. Uebelhoer M; Bewig B; Oldigs M; Nowak D; Magnussen H; Petermann W; Barth J Scand J Clin Lab Invest; 1993 Oct; 53(6):617-23. PubMed ID: 8266009 [TBL] [Abstract][Full Text] [Related]
11. Proliferative activity in fibrosing lung diseases: a comparative study of Ki-67 immunoreactivity in diffuse alveolar damage, bronchiolitis obliterans-organizing pneumonia, and usual interstitial pneumonia. El-Zammar O; Rosenbaum P; Katzenstein AL Hum Pathol; 2009 Aug; 40(8):1182-8. PubMed ID: 19368952 [TBL] [Abstract][Full Text] [Related]
12. [Cytology and phospholipid content of the bronchoalveolar lavage liquid in diffuse interstitial pneumopathies and in sarcoidosis. Apropos of 96 lavages]. Sallerin F; Prévost MC; De Graeve P; Miguères J; Krempf M; Jover A Rev Mal Respir; 1984; 1(3):181-5. PubMed ID: 6473890 [TBL] [Abstract][Full Text] [Related]
13. [Pathogenetic aspects of sarcoidosis. Importance of local complement synthesis in alveolar macrophages]. Pettersen HB; Johnson E Tidsskr Nor Laegeforen; 1992 May; 112(12):1570-3. PubMed ID: 1615506 [TBL] [Abstract][Full Text] [Related]
14. Proportional analysis of respiratory cells obtained by bronchoalveolar lavage. Braude AC; Chamberlain DW; Rebuck AS Can Med Assoc J; 1982 Jun; 126(12):1401-3. PubMed ID: 7083096 [TBL] [Abstract][Full Text] [Related]
15. Comparison of alveolar macrophage and blood monocyte oxidative burst response in pulmonary sarcoidosis. Nielsen H; Frederiksen J; Sherson D; Milman N APMIS; 1990 May; 98(5):401-6. PubMed ID: 2162680 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the responsiveness of alveolar T cells to proliferative stimuli and on surface antigens]. Yamaguchi E Hokkaido Igaku Zasshi; 1993 Mar; 68(2):224-36. PubMed ID: 8509065 [TBL] [Abstract][Full Text] [Related]
17. The morphogenesis and classification of diffuse interstitial lung diseases: a clinicopathological approach, based on tissue reaction patterns. Henderson DW Aust N Z J Med; 1984 Oct; 14(5 Suppl 3):735-48. PubMed ID: 6598040 [TBL] [Abstract][Full Text] [Related]
18. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815 [TBL] [Abstract][Full Text] [Related]
19. [A study on Fc-receptor activity of pulmonary alveolar macrophages in sarcoidosis]. Nakano I; Terai T; Tsuneta Y; Ohsaki Y; Kawakani Y Nihon Kyobu Shikkan Gakkai Zasshi; 1983 Nov; 21(11):1031-7. PubMed ID: 6677777 [No Abstract] [Full Text] [Related]
20. Increased alveolar macrophage chemiluminescence and airspace cell superoxide production in active pulmonary sarcoidosis. Calhoun WJ; Salisbury SM; Chosy LW; Busse WW J Lab Clin Med; 1988 Aug; 112(2):147-56. PubMed ID: 2840475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]